Abstract:Purpose: This study is aimed at developing a clinic-friendly proteomics protocol and a machine learning (ML)-based molecular diagnostic test for T-cell-mediated rejection (TCMR) using formalin-fixed, paraffin-embedded (FFPE) biopsies. Experimental design: Based on the procedures we reported for proteomic profiling of FFPE biopsies using Tandem Mass Tag (TMT)-based technology, a label-free-based quantitative proteomics protocol was developed as a more clinical-practical and cost-efficient molecular diagnostic test for renal transplant injection. This new protocol was applied to a set of FFPE biopsies from renal allograft injury patients and normal controls, including 5 TCMR, 5 polyomavirus BK nephropathy (BKPyVN) and 5 stable graft function (STA). Three different machine learning algorithms, linear discriminant analysis (LDA), support vector machine (SVM) and random forests (RF), were tested to build a prediction model for TCMR. Results: About 750-1250 proteins were identified and quantified in each sample with high confidence using the label-free-based proteomics protocol. 178, 450 and 281 proteins were defined as differential expression (DE) proteins for TCMR vs STA, BKPyVN vs STA and TCMR vs BKPyVN, respectively. By comparing the quantitative data from the TMT- and label-free-based proteomics profiling, a classifier panel comprised of 234 DE proteins commonly quantified by two methods was generated to test different ML algorithms. Leave-one-out cross-validation result suggested that the RF-based model achieved the best prediction power for TCMR at both proteome and transcriptome level. Conclusions and clinical relevance: Proteomics profiling of FFPE biopsies using a platform integrated of label-free quantitative proteomics with ML-based predictive model can help to discover biomarker panels and provide clinical molecular diagnostic tests to enhance biopsy interpretation for renal allograft rejection.

Diagnosis of T-Cell-Mediated Kidney Rejection by Biopsy-Based Proteomics and Machine Learning